Navigation Links
Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
Date:6/10/2009

ded, "DuraTech was easy to use, handled well and provided the flexibility needed for different surgical procedures quickly taking the shape of the underlying tissue."

DuraTech is the leading product in Osteotech's HCT platform, which is based on Osteotech's breakthrough and proprietary first-in-class biomaterial. DuraTech will provide surgeons with greater flexibility to cut, shape and suture the material to fit each patient's needs. Based on available data, Osteotech estimates that the annual market for dural repair substitutes is approximately $100 million.

In addition to DuraTech, which is expected to launch late this year, Osteotech plans to introduce additional tissue products based upon its HCT platform over the next several years that address patient needs and expand the addressable market for this innovative technology. These products include: rotator cuff repair, wound care applications and abdominal wall reconstruction; Osteotech estimates that this expanded addressable market opportunity will eventually be in excess of $1 billion yearly.

"We remain on track to file our 510(k) for DuraTech during the third quarter of 2009 and anticipate clearance of the product before the end of the year," said Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer. "We look forward to evaluating the results of the clinical trial and believe that the data will show that our first-in-class biomaterial stimulates the body's natural healing processes and helps reduce the potential for immune reactions. Our HCT platform will support a variety of new products currently in development and we are excited about its future. We believe the technology platform will yield safe and clinically effective regenerative healing products that can satisfy the emerging needs of surgeons and the patient communities they serve."

About DuraTech(TM) BioRegeneration Matrix

Utilizing Osteotech's
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
2. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
3. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
4. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
5. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
6. Major Restless Legs Study Completes Enrollment With Support From MediciGlobal
7. QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
8. Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
9. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
10. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
11. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 Insulet Corporation (NASDAQ: PODD ), ... OmniPod ® Insulin Management System, today announced preliminary ... 2015. The Company also announced that it will postpone ... and conference call from Thursday, July 30, as originally ... Highlights: , Preliminary second quarter ...
(Date:7/29/2015)... SANTA MONICA, Calif. , July 29, 2015 /PRNewswire/ ... to the San Diego Marriott Marquis & Marina on ... the medical device industry. A highlight of the Business ... Secure Financial Backing from Different Types of Investors, featuring ... Johnson & Johnson Development Corporation; Brent Ahrens , ...
(Date:7/29/2015)... 29, 2015  According to data released today by ... average monthly Medicare Part D premium is expected to ... was originally projected, the Pharmaceutical Care Management Association (PCMA) ... to be a bright spot in American health care. ... region and using cutting edge, cost-saving tools like pharmacy ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5MEDevice San Diego Offers Tips on Securing Financial Backing from Investors 2
(Date:7/30/2015)... ... 30, 2015 , ... New research finds some distinct differences in the way ... on the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, ... cases of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) ...
(Date:7/30/2015)... Angeles, California (PRWEB) , ... July 30, 2015 , ... ... August 5th 2015 - “Learn How to Make Money in the Booming Homecare Business.” ... Los Angeles CA 90010. , The event will be hosted by ...
(Date:7/30/2015)... ... 2015 , ... After conducting a nationwide executive search led by healthcare leadership ... Far Rockaway, N.Y., has hired Gerard (Jerry) Walsh as Chief Executive Officer. Walsh assumed ... leadership experience, Walsh is an expert in organizational change, physician development, implementation of quality ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... with its Medicare administrative contractor (MAC) over submitted claims for bariatric surgery that, ... a challenge to program integrity, Becky Dennis, a nurse auditor at WellSpan Health, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... largest amount of research grants in its history of funding brain aneurysm research. ... who have dedicated their life’s work toward scientific research directed at early detection, ...
Breaking Medicine News(10 mins):Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4
... drugs meant for treating HIV patients also served to protect ... the same can be applied to human beings also has ... ,Rhesus monkeys were experimented upon by the ... them with a version of the Truvada, manufactured by Gilead ...
... older adults due to brain related changes, according to ... easy where younger adults are concerned. The healthy middle ... good where concentrating is concerned, according to functional magnetic ... of the Rotman Research Institute at the Baycrest Center ...
... rates of patients, specific for every surgeon in Scotland has ... community. A majority of the surgeons feel that the ... the surgeon, list of hospitals in which the surgeon has ... the associated mortality rate are amongst the details published. The ...
... that there has been an increase in heart failure cases among ... with men surviving for longer periods. There has been a ... to 1994 period when compared to the 1970 to 1974 period, ... the study. ,The chances of heart failure occurring ...
... National Institute of Immunology are reported to have identified ... the tuberculosis (TB) bacteria survives in the human body. ... more effective medicines to combat the disease, which claims ... annually. The research team led by Rajesh S. Gokhale ...
... A team of researchers led by Dr Stephen Harbarth have ... to be useful in reducing the // infection rates ... by the NHS in dealing with the bug. ... in patient swabs. The researchers said that this test was ...
Cached Medicine News:Health News:The Publication Of Surgeon Specific Death Rates Raises Controversy 2
1.5 mm x 12 mm tip. Angled 15 degrees. Teflon coated with diathermy attachment....
2 mm diameter blade. Angled 60 degrees. Sharp. Round handle....
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle....
1.25 mm x 2.5 mm blade. 135 degrees back scratcher. Round handle....
Medicine Products: